Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 258 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Goulis, Dimitrios G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Goulis, D. G., & Lambrinoudaki I. (2015).  Menopausal hormone therapy for the prevention of cardiovascular disease: Evidence-based customization.. Maturitas. 81(4), 421-2.
Paschou, S. A., Goulis D. G., Lambrinoudaki I., & Papanas N. (2020).  Menopausal hormone therapy for women with obesity in the era of COVID-19.. Case Rep Womens Health. 27, e00233.
Polyzos, S. A., Lambrinoudaki I., & Goulis D. G. (2022).  Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease.. Hormones (Athens).
Anagnostis, P., & Goulis D. G. (2019).  Menopause and its Cardiometabolic Consequences: Current Perspectives.. Curr Vasc Pharmacol. 17(6), 543-545.
Polyzos, S. A., & Goulis D. G. (2024).  Menopause and metabolic dysfunction-associated steatotic liver disease.. Maturitas. 108024.
Karageorgiou, V., Lambrinoudaki I., & Goulis D. G. (2020).  Menopause in women with multiple sclerosis: A systematic review.. Maturitas. 135, 68-73.
Anagnostis, P., Bitzer J., Cano A., Ceausu I., Chedraui P., Durmusoglu F., et al. (2020).  Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.. Maturitas. 135, 82-88.
Anagnostis, P., Lambrinoudaki I., Stevenson J. C., & Goulis D. G. (2022).  Menopause-associated risk of cardiovascular disease.. Endocr Connect. 11(4), 
Paschou, S. A., Vryonidou A., Melissourgou M., Kosteria I., Goulis D. G., Chrousos G. P., et al. (2020).  MENSTRUAL DISORDERS AND ANDROGEN-RELATED TRAITS IN YOUNG WOMEN WITH TYPE 1 DIABETES MELLITUS: A CLINICAL STUDY.. Endocr Pract.
Toulis, K. A., Goulis D. G., Mintziori G., Kintiraki E., Eukarpidis E., Mouratoglou S-A., et al. (2011).  Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome.. Hum Reprod Update. 17(6), 741-60.
Mintziori, G., Duntas L. H., Veneti S., & Goulis D. G. (2022).  Metabolic, Oxidative and Psychological Stress as Mediators of the Effect of COVID-19 on Male Infertility: A Literature Review.. Int J Environ Res Public Health. 19(9), 
Grammatikopoulou, M. G., Theodoridis X., Gkiouras K., Lampropoulou M., Petalidou A., Patelida M., et al. (2019).  Methodological quality of clinical practice guidelines for nutrition and weight gain during pregnancy: a systematic review.. Nutr Rev.
Aggeli, C., Patelida M., Grammatikopoulou M. G., Matzaridou E-A., Berdalli M., Theodoridis X., et al. (2022).  Moderators of Food Insecurity and Diet Quality in Pairs of Mothers and Their Children.. Children (Basel). 9(4), 
Anagnostis, P., Karras S. N., & Goulis D. G. (2014).  Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?. Curr Med Res Opin. 30(6), 1177-8.
N
Anagnostis, P., Gkekas N. K., Potoupnis M., Kenanidis E., Tsiridis E., & Goulis D. G. (2019).  New therapeutic targets for osteoporosis.. Maturitas. 120, 1-6.
Grammatikopoulou, M. G., Gkouskou K. K., Gkiouras K., Bogdanos D. P., Eliopoulos A. G., & Goulis D. G. (2022).  The Niche of n-of-1 Trials in Precision Medicine for Weight Loss and Obesity Treatment: Back to the Future.. Curr Nutr Rep. 11(2), 133-145.
Vachliotis, I. D., Anastasilakis A. D., Goulas A., Goulis D. G., & Polyzos S. A. (2022).  Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.. Diabetes Obes Metab. 24(9), 1702-1720.
Polyzos, S. A., Goulis D. G., & Kountouras J. (2015).  Nonalcoholic fatty liver disease and polycystic ovary syndrome.. Ann Hepatol. 14(6), 941-3.
Polyzos, S. A., Mousiolis A., Mintziori G., & Goulis D. G. (2020).  Nonalcoholic fatty liver disease in males with low testosterone concentrations.. Diabetes Metab Syndr. 14(5), 1571-1577.
Polyzos, S. A., Goulis D. G., Kountouras J., Mintziori G., Chatzis P., Papadakis E., et al. (2014).  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.. Hormones (Athens). 13(4), 519-31.
Paschou, S. A., Polyzos S. A., Anagnostis P., Goulis D. G., Kanaka-Gantenbein C., Lambrinoudaki I., et al. (2019).  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.. Endocrine.
Anagnostis, P., Vaitsi K., Mintziori G., Goulis D. G., & Mikhailidis D. P. (2020).  Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.. Curr Med Res Opin. 1-10.
Mintziori, G., Goulis D. G., Lambrinoudaki I., Ceausu I., Depypere H., C Erel T., et al. (2015).  Non-hormonal management of menopausal vasomotor symptoms: Psychosocial interventions.. Maturitas. 82(4), 444-5.
Mareti, E., Ampatzi C., Paschou S. A., Voziki E., & Goulis D. G. (2019).  Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?. Curr Vasc Pharmacol. 17(6), 573-578.
O
Sirimi, N., & Goulis D. G. (2010).  Obesity in pregnancy.. Hormones (Athens). 9(4), 299-306.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές